13F Holdings
中文EN

Lynx1 Capital Management LP

DORADO PR · SEC CIK 0001910456

2026Q22026Q1 9 earlier quarters 🔒
$865.53M2026Q2 reported value
27Positions
98.8%Top 10 weight · largest 41.2%
6 / 2New / sold out
Reported value over time$865.53M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

GHRS 41.2%
CGEM 18.9%
STOK 15.3%
AGIO 14.6%
CCCC 4.0%
KRRO 2.3%
TSCAN THERAPEU 0.9%
DTIL 0.9%
NEUPHORIA THER 0.4%
PASSAGE BIO IN 0.4%

2026Q2 top buys estimated at quarter-end value

GHRS Added+$67.20M
AGIO Added+$29.59M
PLIANT THERAPEUT New+$2.05M
CCCC Added+$1.53M
PROQR THRAPEUTIC Added+$842,444

2026Q2 top sells estimated at quarter-end value

DNLI Reduced-$48.06M
STOK Reduced-$23.73M
XNCR Reduced-$8.34M
IMTX Reduced-$1.96M
DSGN Sold out-$1.27M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
GHRS GH RESEARCH PLC $356.52M41.19%13,263,288 2,500,00023.2% $67.20M Added
CGEM CULLINAN THERAPEUTICS INC $163.23M18.86%8,963,500 00.0% — Unchanged
STOK STOKE THERAPEUTICS INC $132.14M15.27%4,038,404 -725,269-15.2% -$23.73M Reduced
AGIO AGIOS PHARMACEUTICALS INC $126.51M14.62%3,408,937 797,36930.5% $29.59M Added
CCCC C4 THERAPEUTICS INC $34.22M3.95%7,326,691 327,7894.7% $1.53M Added
KRRO KORRO BIO INC $20.27M2.34%1,538,296 00.0% — Unchanged
— TSCAN THERAPEUTICS INC $7.86M0.91%8,019,148 00.0% — Unchanged
DTIL PRECISION BIOSCIENCES INC $7.47M0.86%950,466 -34,647-3.5% -$272,325 Reduced
— NEUPHORIA THERAPEUTICS INC $3.83M0.44%875,328 00.0% — Unchanged
— PASSAGE BIO INC $3.29M0.38%673,759 50,0558.0% $244,268 Added
CGON CG ONCOLOGY INC $2.23M0.26%31,391 -200-0.6% -$14,210 Reduced
— PLIANT THERAPEUTICS INC $2.05M0.24%1,798,070 1,798,070— $2.05M New
TRDA ENTRADA THERAPEUTICS INC $1.31M0.15%178,606 -33,083-15.6% -$243,491 Reduced
— VYNE THERAPEUTICS INC $1.06M0.12%1,628,700 00.0% — Unchanged
— PROQR THRAPEUTICS N V $969,8280.11%521,413 452,927661.3% $842,444 Added
— TRAWS PHARMA INC $471,8010.05%559,470 544,3923,610.5% $459,086 Added
FHTX FOGHORN THERAPEUTICS INC $300,5490.03%61,588 61,588— $300,549 New
DNLI DENALI THERAPEUTICS INC $299,8440.03%11,658 -1,868,645-99.4% -$48.06M Reduced
XNCR XENCOR INC $292,9230.03%18,194 -518,204-96.6% -$8.34M Reduced
ABSI ABSCI CORPORATION $246,2300.03%21,245 00.0% — Unchanged
— WEREWOLF THERAPEUTICS INC $236,7370.03%657,786 00.0% — Unchanged
IMTX IMMATICS N.V $235,3810.03%23,236 -193,737-89.3% -$1.96M Reduced
AVTX AVALO THERAPEUTICS INC $186,6480.02%10,100 10,100— $186,648 New
— BOLT BIOTHERAPEUTICS INC $118,5800.01%30,800 00.0% — Unchanged
NUVB NUVATION BIO INC $91,0450.01%16,029 16,029— $91,045 New
EPRX EUPRAXIA PHARMACEUTICALS INC $66,1000.01%10,000 10,000— $66,100 New
IKT INHIBIKASE THERAPEUTICS INC $40,6000.00%20,000 20,000— $40,600 New
DSGN DESIGN THERAPEUTICS INC $00.00%0 -119,516-100.0% -$1.27M Sold out
— IBIO INC $00.00%0 -68,076-100.0% -$129,344 Sold out